Haddadin Yezan Munther bought OTLK

June 2, 2026 · Form 4 insider transaction

Haddadin Yezan Munther bought 29,000 shares of Outlook Therapeutics, Inc. at $0.83 per share, a transaction worth $24.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.